Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
8. Insys—$225 million
Bankrupt Insys cleared to sell opioid spray Subsys in $20M deal
Friday, September 20, 2019
Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.
Insys files for bankruptcy after $255M kickback settlement
Monday, June 10, 2019
When Insys settled with the feds for $225 million, the drugmaker hoped it had put its troubled past behind it. Now they’re filing for bankruptcy.
Embattled Insys will pay $225M to wrap Subsys kickback probe
Thursday, June 6, 2019
After federal prosecutors bagged multiple former execs, Insys had to know its day of reckoning was near. Now it's here—and it'll cost $225 million.
Purdue faces 5 new state lawsuits after Oklahoma settlement
Friday, May 17, 2019
Purdue took a big hit when it settled with Oklahoma over claims it misleadingly advertised its powerful opioid, OxyContin. Now more states want in.
Kapoor found guilty in landmark opioid bribery suit
Thursday, May 2, 2019
Insys founder John Kapoor was found guilty on federal racketeering charges in a landmark case nailing C-level executives in the U.S. opioid epidemic.
Former Insys VP to pay $9.5M in opioid spray kickback scheme
Wednesday, April 3, 2019
Insys’ former VP of sales has turned state's evidence in an Arizona kickback suit alleging company executives drove a scheme to buy Subsys scripts.
Ex-Insys manager demands mistrial after topless photo testimony
Tuesday, March 5, 2019
In an Insys Therapeutics case that’s already full of shocking details, prosecutors just upped the ante.
Insys opioid reps rapped about getting docs on the gravy train
Thursday, February 14, 2019
During Insys founder John Kapoor's criminal trial, prosecutors played a video urging sales reps to break the rules when promoting its opioid Subsys.
Insys drove ‘explosive growth’ of opioids by ‘owning’ physicians: report
Thursday, October 18, 2018
The U.S. Senate has released a report on Insys that provides an insider’s view of a company leaning on physicians to help drive sales.